title: Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.
abstract: Men have higher prevalence rates of chronic obstructive pulmonary disease (COPD) than women, which has been attributed to the historically higher rates of cigarette smoking in males. However, the increased rates of cigarette smoking in females within the last several decades have been associated with steadily increasing rates of COPD in women. As part of a study of the genetics of severe, early-onset COPD, we assembled a group of 84 probands with severe, early-onset COPD (without severe alpha(1)-antitrypsin deficiency) and 348 of their first-degree relatives. We found a markedly elevated prevalence (71.4%) of females among the early-onset COPD probands. Among the entire group of first-degree relatives of early-onset COPD probands, univariate analysis demonstrated similar spirometric values and bronchodilator responsiveness in males and females; however, among current or ex-smokers, female first-degree relatives had significantly lower FEV(1)/ FVC (81.4 +/- 17.2% in females versus 87.0 +/- 12.9% in males, p = 0.009) and significantly greater bronchodilator responsiveness (expressed as percentage of baseline FEV(1)) (7.7 +/- 9.4% pred in females versus 4.1 +/- 6.4% pred in males, p = 0.002). Female smoking first-degree relatives were significantly more likely to demonstrate profound reductions in FEV(1) (< 40% pred) than male smoking first-degree relatives (p = 0. 03). Multivariate analysis, performed with generalized estimating equations, demonstrated that current or ex-smoking female first-degree relatives had significantly greater risk of FEV(1) < 80% pred (OR 1.91, 95% CI 1.03- 3.54), FEV(1) < 40% pred (OR 3.56, 95% CI 1.08-11.71), and bronchodilator response greater than 10% of baseline FEV(1) (OR 4.74, 95% CI 1.91-11.75). These results suggest that women may be more susceptible to the development of severe COPD.
authors: Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. ed.silverman@channing.harvard.edu
authors: E K
authors: EK
authors: Silverman
authors: S T
authors: ST
authors: Weiss
authors: J M
authors: JM
authors: Drazen
authors: H A
authors: HA
authors: Chapman
authors: V
authors: V
authors: Carey
authors: E J
authors: EJ
authors: Campbell
authors: P
authors: P
authors: Denish
authors: R A
authors: RA
authors: Silverman
authors: J C
authors: JC
authors: Celedon
authors: J J
authors: JJ
authors: Reilly
authors: L C
authors: LC
authors: Ginns
authors: F E
authors: FE
authors: Speizer
mesh_terms: D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay; D005192:Family Health; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000175:diagnosis* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D013902:Radiography, Thoracic; D012727:Sex Characteristics; D012907:Smoking / Q000009:adverse effects; D013147:Spirometry / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014057:Tomography, X-Ray Computed; D000515:alpha 1-Antitrypsin / Q000032:analysis
chemical_list: D000515:alpha 1-Antitrypsin